MYD88 and cardiovascular disorder: While this pathway was initially characterized in innate cells, it has been found that MyD88 is broadly expressed across most cell types of the immune system and cardiovascular systems, often exerting distinct roles specific to certain cell types within cardiovascular disease contexts (Blagov et al., 2023).